Analysis of cases with co-infection of COVID-19 and pulmonary aspergillosis
This study included 201 COVID-19 patients from December 1, 2022, to January 31, 2023; 7 (3.5%) were diagnosed with CAPA. The main risk factors were age, MV, ICU admission and COPD, and the presence of comorbidities such as ARDS and hypoproteinemia in COVID-19 patients, more susceptible to Aspergillus infection. In addition to specimen culture in the lower respiratory tract, the 1,3-β-D-glucan antigen test can serve as an important screening indicator for early CAPA diagnosis in non-granulocytopenia patients.PMID:38700889
Source: New Microbiologica - Category: Microbiology Authors: Hui Zheng Hu Li Bo Wu Qian Liu Bin Yan Wu Yu Wang Rui Ying Wang Source Type: research
More News: Aspergillosis | Aspergillus | Chronic Obstructive Pulmonary | COVID-19 | Microbiology | Respiratory Medicine | Study